RxDoctor Payments Data

Michael Giovanniello, MD

Physical Medicine & Rehabilitation · Sandy, UTNPI 1285604462

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,495 of the $6,207 with a category attached, or 72.4%. It is spread thinly across 44 manufacturers, the largest accounting for just 19.3%. Reporting peaked in 2021 at $2,426 and has fallen 78.0% since, to $534 in 2025. Among physical medicine & rehabilitation clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,207in general payments, 2019–2025

Across 236 payments — averaging $26.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kairos Surgical Inc$1K
  • AbbVie$921
  • Relievant Medsystems, Inc.$799
  • Boston Scientific$333
  • Collegium Pharmaceutical, Inc.$276
  • Teva Pharmaceuticals USA, Inc.$229
  • plus $2K from 38 others
$128,887in research payments, 2019–2025

Across 11 payments — averaging $11,717 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$66K
  • Pacira Therapeutics, Inc.$63K

What the payments were for

  • Travel & lodging$5138%
  • Food & beverage$4,49572%
  • Education$1,20019%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,207 in reported general payments places this provider in the 90th percentile of 117 physical medicine & rehabilitation providers in Utah.

See all physical medicine & rehabilitation providers in Utah

Medicare billing

Part B allowed, 2024
$73,957
Medicare patients
82
Services billed
3,120

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl59$11,633
Xtampza ErOxycodone Myristate12$11,593
OxycontinOxycodone Hcl21$9,765
Nucynta ErTapentadol Hcl12$6,814
NucyntaTapentadol Hcl12$5,876
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen98$4,987
Oxycodone Hcl168$3,596
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen93$2,558
Morphine Sulfate ErMorphine Sulfate53$1,426
Gabapentin72$1,406
Fentanyl12$1,231
Tramadol Hcl53$751
Celecoxib60$729
Tizanidine Hcl39$540
Methadone Hcl11$388

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta Er, Nucynta$276$24,28336 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 117 physical medicine & rehabilitation providers in Utah.

Other physical medicine & rehabilitation in Sandy

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →